• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人群前列腺癌病理特征的研究。

Study of prostate cancer pathologic features in Chinese populations.

作者信息

Chuang Ai-Ying, Chang Shu-Jen, Horng Cheng-Fang, Tsou Mei-Hua

机构信息

Department of Pathology and Laboratory Medicine, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.

出版信息

Urology. 2007 May;69(5):915-20. doi: 10.1016/j.urology.2007.01.051.

DOI:10.1016/j.urology.2007.01.051
PMID:17482934
Abstract

OBJECTIVES

To report the pathologic features of prostate cancer and its clinical outcome in the Chinese population in Taiwan.

METHODS

A total of 139 radical prostatectomy specimens removed at Koo Foundation Sun Yat-Sen Cancer Center from 1993 to 2001 were reviewed.

RESULTS

The median patient age was 69 years. The histologic type was acinar adenocarcinoma in 137, mucinous adenocarcinoma in 1, and ductal adenocarcinoma in 1. The median tumor number in each prostate gland was 2. The main tumor location was distributed in peripheral zone (76.3%), followed by the transitional zone (15.1%). The Gleason score of the largest tumor was 2 to 4 in 1.5%, 5 to 6 in 7.9%, 7 in 48.9%, and 8 to 10 in 41.7%. Extraprostatic tumor extension, seminal vesicle invasion, and lymph node metastasis were found in 59.0%, 28.8%, and 13.7% of the patients, respectively. Of the 139 specimens, 56 (40.3%), 64 (46.1%), and 19 (13.7%) were pathologic Stage T2, T3, and T4, respectively. The clinical stage (P = 0.0059), serum prostate-specific antigen (PSA) level (greater than 20 ng/mL versus 10 ng/mL or less, P = 0.002), extraprostatic extension (P = 0.0012), seminal vesicle invasion (P <0.0001), and surgical margin status (P <0.0001) were all significant factors for disease progression on univariate analysis. On multivariate analysis, the serum PSA level (greater than 20 ng/mL versus 10 ng/mL or less, P = 0.03), seminal vesicle invasion (P = 0.02), and surgical margin status (P = 0.02) remained significant.

CONCLUSIONS

The patients with prostate cancer cared for at the Koo Foundation Sun Yat-Sen Cancer Center were older and had greater PSA levels, a more advanced stage, higher grade tumors, and high positive surgical margin rates. Increased public awareness and implementing a PSA screening program in Taiwan are of crucial importance.

摘要

目的

报告台湾地区中国人群前列腺癌的病理特征及其临床结局。

方法

回顾了1993年至2001年在国父纪念馆中山癌症中心切除的139例前列腺癌根治术标本。

结果

患者中位年龄为69岁。组织学类型为腺泡腺癌137例,黏液腺癌1例,导管腺癌1例。每个前列腺中肿瘤的中位数为2个。主要肿瘤位置分布在外周区(76.3%),其次是移行区(15.1%)。最大肿瘤的Gleason评分为2至4分的占1.5%,5至6分的占7.9%,7分的占48.9%,8至10分的占41.7%。分别有59.0%、28.8%和13.7%的患者出现前列腺外肿瘤侵犯、精囊侵犯和淋巴结转移。在139例标本中,病理分期T2、T3和T4分别有56例(40.3%)、64例(46.1%)和19例(13.7%)。单因素分析显示,临床分期(P = 0.0059)、血清前列腺特异性抗原(PSA)水平(大于20 ng/mL与10 ng/mL或更低,P = 0.002)、前列腺外侵犯(P = 0.0012)、精囊侵犯(P <0.0001)和手术切缘状态(P <0.0001)均为疾病进展的显著因素。多因素分析显示,血清PSA水平(大于20 ng/mL与10 ng/mL或更低,P = 0.03)、精囊侵犯(P = 0.02)和手术切缘状态(P = 0.02)仍然具有显著性。

结论

在国父纪念馆中山癌症中心接受治疗的前列腺癌患者年龄较大,PSA水平较高,分期较晚,肿瘤分级较高,手术切缘阳性率较高。提高台湾地区公众意识并实施PSA筛查计划至关重要。

相似文献

1
Study of prostate cancer pathologic features in Chinese populations.中国人群前列腺癌病理特征的研究。
Urology. 2007 May;69(5):915-20. doi: 10.1016/j.urology.2007.01.051.
2
Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.对于患有大体积癌症的男性,术前血清前列腺特异性抗原不能反映根治性前列腺切除术后的生化失败率。
J Urol. 2000 Nov;164(5):1596-600.
3
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.淋巴管浸润是前列腺腺癌的一个独立预后因素。
J Urol. 2005 Dec;174(6):2181-5. doi: 10.1097/01.ju.0000181215.41607.c3.
4
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.结合活检侧别与TNM分期的改良临床分期系统用于T1c和T2期前列腺癌男性患者:SEARCH数据库的结果
J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14.
5
Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.神经周围浸润和精囊受累可预测局限性前列腺癌男性患者的盆腔淋巴结转移。
J Urol. 1998 Nov;160(5):1722-6.
6
Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.组织蛋白酶B与丝抑素A的比值对前列腺癌患者盆腔淋巴结转移的预测作用
Cancer. 2002 Jun 15;94(12):3141-9. doi: 10.1002/cncr.10604.
7
The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.活检累及范围作为低危前列腺癌前列腺外侵犯和手术切缘状态的独立预测因素:对治疗选择的影响
J Urol. 2000 Dec;164(6):1982-6.
8
Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.前列腺腺癌侵犯精囊:PSA结果由术前和术后因素决定。
Urology. 2004 Feb;63(2):333-6. doi: 10.1016/j.urology.2003.09.042.
9
The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.根治性前列腺切除标本中手术切缘阳性范围与前列腺特异性抗原复发之间的关系。
Hum Pathol. 2007 Aug;38(8):1207-11. doi: 10.1016/j.humpath.2007.01.006. Epub 2007 May 8.
10
Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.当代根治性前列腺切除术后精囊无转移灶侵犯患者的生存结果及放射治疗的作用
J Urol. 2005 Apr;173(4):1150-5. doi: 10.1097/01.ju.0000155158.79489.48.

引用本文的文献

1
Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study.中国人群中接受根治性前列腺切除术和辅助雄激素剥夺治疗的淋巴结转移患者的结局:一项队列研究的结果
World J Surg Oncol. 2015 May 6;13:172. doi: 10.1186/s12957-015-0597-3.
2
Ductal adenocarcinoma of the prostate: a Hong Kong case series.
Int Urol Nephrol. 2014 Nov;46(11):2133-7. doi: 10.1007/s11255-014-0793-z. Epub 2014 Jul 31.
3
A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.一项基于人群的台湾巢式病例对照研究:5α-还原酶抑制剂的使用并未降低良性前列腺增生患者的前列腺癌风险。
Oncologist. 2012;17(7):986-91. doi: 10.1634/theoncologist.2011-0464. Epub 2012 Jun 20.
4
Scientific publications in nephrology and urology journals from Chinese authors in East Asia: a 10-year survey of the literature.东亚国家作者在肾脏病学和泌尿学期刊上的科学出版物:文献 10 年调查。
PLoS One. 2011 Apr 8;6(4):e14781. doi: 10.1371/journal.pone.0014781.
5
Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China.中国南京人群中筛查诊断与临床诊断前列腺癌的临床病理特征比较。
Med Oncol. 2011 Mar;28(1):357-64. doi: 10.1007/s12032-009-9409-3. Epub 2010 Jan 14.
6
Evaluation of prostate cancer characteristics in four populations worldwide.全球四个人群中前列腺癌特征的评估。
Can J Urol. 2008 Jun;15(3):4056-64.